Landscapes / Targets
VEGF-A
7 drugs act on VEGF-A, in 50 active trials · Any stage · updated 18 Nov 2026
FollowEvery change as it happens, and a Monday email
Drugs7
| Drug | How it works | Company | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
Monoclonal antibody |
Roche · Public ROG.SW |
Approved | 26 Jan 2027Phase 4 trial completes | ||
| How it works | An antibody | ||||
| Next date | 26 Jan 2027 · Phase 4 trial completes | ||||
| Also tested for | Diabetic Macular Edema, Neovascular Age-related Macular Degeneration (nAMD) | ||||
| Open drug page | |||||
— |
Approved in the EU | Dec 2027Phase 3 trial completes | |||
| Next date | Dec 2027 · Phase 3 trial completes | ||||
| Also tested for | Age-Related Macular Degeneration, Neovascular Age-related Macular Degeneration and 3 more | ||||
| Open drug page | |||||
PD-L1/VEGF-A bispecific antibody |
BioNTech +1 · Public BNTX · BMY |
Phase 3 | 1 Jan 2027Phase 2 trial completes | ||
| How it works | A cancer drug that hits two targets at once | ||||
| Next date | 1 Jan 2027 · Phase 2 trial completes | ||||
| Also tested for | Advanced Solid Tumor, SCLC and 49 more | ||||
| Open drug page | |||||
— |
Phase 2/3 | 31 Aug 2027Phase 2/3 trial completes | |||
| Next date | 31 Aug 2027 · Phase 2/3 trial completes | ||||
| Also tested for | Biliary Tract Cancer, Cholangiocarcinoma and 2 more | ||||
| Open drug page | |||||
GNR-139not checked |
— |
Phase 3 | May 2028Phase 3 trial completes | ||
| Next date | May 2028 · Phase 3 trial completes | ||||
| Also tested for | nAMD | ||||
| Open drug page | |||||
— |
Phase 3 | — | |||
| Also tested for | Lung Cancer, Non-small Cell Lung Cancer | ||||
| Open drug page | |||||
— |
Phase 1 | Jun 2028Phase 1 trial completes | |||
| Next date | Jun 2028 · Phase 1 trial completes | ||||
| Also tested for | Neovascular Age-related Macular Degeneration (nAMD), Diabetic Macular Edema (DME) and 1 more | ||||
| Open drug page | |||||
No drugs match “”.
About this list
- Checked
- 6 of 7 drugs. The other 1 is marked “not checked” in the list. How we check
- Matches
- The mechanism of checked drugs, and drug names, so a drug not checked yet may be missing.
- Sources
- ClinicalTrials.gov updated 18 Nov 2026 · openFDA updated 17 Nov 2026